About: Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.
Sector: Healthcare
Industry: Biotechnology
Latest price: $431.00 (-2.12%)
MDGL NASDAQ Madrigal Pharmaceuticals Inc
Carregando status da lista de acompanhamento…
Madrigal Pharmaceuticals Inc share price
Atividade de preço de MDGL
Último preço
$ 431,000
Variação (24h)
-9,33 USD (2,12%)
Volume
297.52K
Volume (média 4 sem.)
-
Abertura
$ 431,01
Variação do dia
$ 425,30 - $ 437,18
Fechamento anterior
$ 440,33
Último negócio
28 Oct, 8:00 pm GMT+0
Atrasado
28 Oct, 8:00 pm GMT+0
MDGL price performance
-0,75%
5D
-15,40%
1M
-25,99%
YTD
+2,23%
1Y
Atrasado
28 Oct, 8:00 pm GMT+0
quote.marketSignals